+
Site Tour

Search

Showing 11 - 20 of 449 results.

  • Patients who benefit

    PATIENTS WHO BENEFIT MR IS THE MOST COMMON VALVULAR HEART DISEASE AND IS SIGNIFICANTLY UNDERTREATED3 More patients are suffering from MR than any other valve disease, and only a small percentage
  • Features

    *The testimonial does not provide any indication, guide, warranty or guarantee as to the response patients may have to the treatment or effectiveness of the product or therapy in discussion. Opinions
  • Overview

    © Abbott 2025. All rights reserved. 9-EH-5-14381-01 05-2025 REV B
  • 404 - Page not found

    404 Page not found The location may have changed Please double-check the web address, look for your topic via search or look at our sitemap.  
  • Connext Live

    © Abbott 2023. All rights reserved. 9-EH-5-14560-01 09-2023
  • TAVI Webinar 2025

    ABBOTT TAVI WEBINARS 2025 Whether you aim at enhancing your skills by joining the advanced TAVI webinars together with P. MacCarthy and a strong pool of experts, or want to capitalize on robust TAV
  • PDA Symposium 2024

    ON DEMAND - PDA SYMPOSIUM 2024 4th PREMICLOSE SYMPOSIUM 2024 (PDA) SESSION 1: Clinical perspectives on the PDA SESSION 2: How (not) to close a PDA SESSION 3: What is that - The Neo-Ped Card Wor
  • Echo Course Webinars

    ON DEMAND Echo Course Webinars 2024 Echo guidance for screening and interventions in structural heart diseases PART 1: ANATOMICAL OVERVIEW ECHO COURSES PART 2: MITRAL-TEER ECHO COURSES PART 3:
  • Site Tour

    MY-CONNEXT SITE TOUR © Abbott 2024. All rights reserved. 9-EH-5-15020-01 03-2024
  • AV Valves SUMMIT 2023

    ON DEMAND AV VALVES SUMMIT 2023 1st global edition of the AtrioVentricular Valves Summit SESSION 1: INTRODUCTION SESSION 2: TRENDING TOPICS SESSION 3: NAVIGATING THE ANATOMY SESSION 4: MITRAL

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline